Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hassel

Showing results (151-160 of 322) with videos related to

Pageof 33
Sort By:
European Journal of Cancer (Oxford, England : 1990)|September 4, 2020
Programmed cell death protein 1 inhibitors in advanced cutaneous squamous cell carcinoma: real-world data of a retrospective, multicenter studyMartin Salzmann, Ulrike Leiter, Carmen Loquai, et al.
Bone Marrow Transplantation|January 20, 2026
Intermediate-dose TBI/fludarabine conditioning for allogeneic hematopoietic cell transplantation in patients with cutaneous T-cell lymphomaIsabelle Krämer, Laila König, Arne Brecht, et al.
Life (Basel, Switzerland)|April 3, 2021
Expression of Potential Targets for Cell-Based Therapies on Melanoma CellsSophia B Strobel, Devayani Machiraju, Ingrid Hülsmeyer, et al.
Oncoimmunology|June 9, 2021
Soluble immune checkpoints and T-cell subsets in blood as biomarkers for resistance to immunotherapy in melanoma patientsDevayani Machiraju, Melanie Wiecken, Nina Lang, et al.
BMC Urology|July 15, 2015
Primary melanoma of the prostate: case report and review of the literatureGeorgi Tosev, Timur H Kuru, Johannes Huber, et al.
Physical Review Letters|January 18, 2018
Characterization of the ^{163}Ho Electron Capture Spectrum: A Step Towards the Electron Neutrino Mass DeterminationP C-O Ranitzsch, C Hassel, M Wegner, et al.
Oncoimmunology|December 24, 2024
The immune checkpoint LAG-3 is expressed by melanoma cells and correlates with clinical progression of the melanomaMelanie Wiecken, Devayani Machiraju, Shounak Chakraborty, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 11, 2015
Erythema nodosum-like lesions during BRAF inhibitor therapy: Report on 16 new cases and review of the literatureR Mössner, L Zimmer, C Berking, et al.
Cancers|December 9, 2023
C-Type Lectin-like Receptor 2 Expression Is Decreased upon Platelet Activation and Is Lower in Most Tumor Entities Compared to Healthy ControlsMani Etemad, Foteini Christodoulou, Stefanie Uhlig, et al.
Cancer Immunology, Immunotherapy : CII|October 12, 2017
Characterization of arthralgia induced by PD-1 antibody treatment in patients with metastasized cutaneous malignanciesKristina Buder-Bakhaya, Karolina Benesova, Carsten Schulz, et al.
Pageof 33

Showing results (151-160 of 322) with videos related to

Sort By:
Pageof 33
European Journal of Cancer (Oxford, England : 1990)|September 4, 2020
Programmed cell death protein 1 inhibitors in advanced cutaneous squamous cell carcinoma: real-world data of a retrospective, multicenter studyMartin Salzmann, Ulrike Leiter, Carmen Loquai, et al.
Bone Marrow Transplantation|January 20, 2026
Intermediate-dose TBI/fludarabine conditioning for allogeneic hematopoietic cell transplantation in patients with cutaneous T-cell lymphomaIsabelle Krämer, Laila König, Arne Brecht, et al.
Life (Basel, Switzerland)|April 3, 2021
Expression of Potential Targets for Cell-Based Therapies on Melanoma CellsSophia B Strobel, Devayani Machiraju, Ingrid Hülsmeyer, et al.
Oncoimmunology|June 9, 2021
Soluble immune checkpoints and T-cell subsets in blood as biomarkers for resistance to immunotherapy in melanoma patientsDevayani Machiraju, Melanie Wiecken, Nina Lang, et al.
BMC Urology|July 15, 2015
Primary melanoma of the prostate: case report and review of the literatureGeorgi Tosev, Timur H Kuru, Johannes Huber, et al.
Physical Review Letters|January 18, 2018
Characterization of the ^{163}Ho Electron Capture Spectrum: A Step Towards the Electron Neutrino Mass DeterminationP C-O Ranitzsch, C Hassel, M Wegner, et al.
Oncoimmunology|December 24, 2024
The immune checkpoint LAG-3 is expressed by melanoma cells and correlates with clinical progression of the melanomaMelanie Wiecken, Devayani Machiraju, Shounak Chakraborty, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 11, 2015
Erythema nodosum-like lesions during BRAF inhibitor therapy: Report on 16 new cases and review of the literatureR Mössner, L Zimmer, C Berking, et al.
Cancers|December 9, 2023
C-Type Lectin-like Receptor 2 Expression Is Decreased upon Platelet Activation and Is Lower in Most Tumor Entities Compared to Healthy ControlsMani Etemad, Foteini Christodoulou, Stefanie Uhlig, et al.
Cancer Immunology, Immunotherapy : CII|October 12, 2017
Characterization of arthralgia induced by PD-1 antibody treatment in patients with metastasized cutaneous malignanciesKristina Buder-Bakhaya, Karolina Benesova, Carsten Schulz, et al.
Pageof 33